SCHEMBL2667185

SCHEMBL2667185

CN1CCOc2cc(Oc3cc(O)cc(C(=O)Nc4cc[nH]n4)c3)ccc2C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 4/20 0.35
KCNH2 Q12809 2/20 0.34
GRM5 P41594 1/20 0.34
CCNA2 P20248 2/20 0.34
CDK2 P24941 2/20 0.34
CCNA1 P78396 2/20 0.34
KDR P35968 5/20 0.33
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
ALDH1A1 P00352 1/20 0.32
NTRK1 P04629 2/20 0.32
FLT3 P36888 2/20 0.32
FGFR1 P11362 1/20 0.32
NTRK3 Q16288 1/20 0.32
NTRK2 Q16620 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LCK P06239 1/20 0.32
MET P08581 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2667143 0.91 CCNA2 (0.35) GCKKCNH2CCNA2CDK2CCNA1
SCHEMBL1775458 0.89 GCK (0.45) GCKKCNH2
SCHEMBL1776485 0.86 GCK (0.52) GCKKCNH2GRM5
SCHEMBL1774688 0.85 GCK (0.49) GCKKCNH2
SCHEMBL1776173 0.82 ROCK2 (0.40) GRM5ROCK2ROCK1ALDH1A1SMN1; SMN2
SCHEMBL1774522 0.81 GCK (0.44) GCKKCNH2
SCHEMBL12784505 0.80 GCK (0.38) GCKKCNH2CCNA2CDK2CCNA1
SCHEMBL1775288 0.79 GCK (0.51) GCKKCNH2GRM5
SCHEMBL2667121 0.78 GCK (0.46) GCKKCNH2NPC1RAB9A
SCHEMBL2667146 0.77 GCK (0.44) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006125972-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2006-11-30 WO disclosed